Clinical trial

Assessing the Frequency of Lidocaine Ineffectiveness in the General Population vs. Males With ADHD, and Females With ADHD, With or Without PMS

Name
2018-272
Description
This work will assess the prevalence in the general population of the ineffectiveness of the anesthetic Lidocaine compared to males with ADHD and females with ADHD with or without PMS.
Trial arms
Trial start
2019-08-14
Estimated PCD
2020-03-01
Trial end
2020-03-01
Status
Completed
Phase
Early phase I
Treatment
Lidocaine gel
Lidocaine gel (0.75 g premeasured dose of Septodont 5% oral gel NDC 0362-0221-10)
Arms:
All subjects
Other names:
Intervention
Size
90
Primary endpoint
Number of Subjects With Lidocaine Ineffectiveness
30 minute visit, added on to a regular clinic visit
Eligibility criteria
Inclusion Criteria: Exclusion Criteria for both arms: (1) known adverse reactions to lidocaine; (2) ADHD, ADD, and other inattention disorders; (3) epilepsy, IQ \<80, severe head trauma, birth weight \<2270 grams, and severe autism; (4) treatment currently with potassium or potassium-elevating drugs such as renin-angiotensin-aldosterone blockers; (5) generalized anxiety disorders (but dental-specific anxiety will not be an exclusion because many of these individuals may be ones with anxiety because of painful dental experiences with lidocaine ineffectiveness); (6) mouth sores; (7) Ehlers Danlos syndrome, (8) red hair, and (9) current pregnancy.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'A group of 100 subjects will be assessed.', 'primaryPurpose': 'HEALTH_SERVICES_RESEARCH', 'maskingInfo': {'masking': 'NONE', 'maskingDescription': "The scoring of the lidocaine test is masked, using the coded identity of the tastes. The tastes will be assessed in random order. The subjects and other study personnel will be told not to discuss what the subject could or couldn't taste. Scoring will not be shared with the testing site until all testing is complete."}}, 'enrollmentInfo': {'count': 90, 'type': 'ACTUAL'}}
Updated at
2022-10-06

1 organization

1 product

2 indications

Product
Lidocaine
Indication
ADHD
Organization
PhenoSolve